Amanta Healthcare Intrinsic Value
Amanta Healthcare (AMANTA) median intrinsic value is ₹77.20 from 9 valuation models (range ₹38–₹217), vs current price ₹126.35 — -38.9% downside (Trading Above Calculated Value), margin of safety -63.7%. Also explore Amanta Healthcare stock price data download to track price trends across different timeframes.
AMANTA Valuation Methods Summary — DCF, Graham Number & P/E
Amanta Healthcare intrinsic value across 9 models vs current price ₹126.35 — upside/downside and value range per method. For current market price and key ratios, visit Amanta Healthcare share price today.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹110.00 | ₹88.00 - ₹132.00 | -12.9% | EPS: ₹5.00, Sector P/E: 22x |
| Book Value Method | asset | ₹66.21 | ₹59.59 - ₹72.83 | -47.6% | Book Value/Share: ₹33.10, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹196.55 | ₹176.90 - ₹216.21 | +55.6% | Revenue/Share: ₹98.28, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹217.24 | ₹195.52 - ₹238.96 | +71.9% | EBITDA: ₹63.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹189.25 | ₹151.40 - ₹227.10 | +49.8% | CF Growth: 11.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹37.90 | ₹34.11 - ₹41.69 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹77.20 | ₹69.48 - ₹84.92 | -38.9% | Revenue Growth: 5.9%, Adj P/E: 15.4x |
| ROE Based Valuation | profitability | ₹72.41 | ₹65.17 - ₹79.65 | -42.7% | ROE: 15.6%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹61.03 | ₹54.93 - ₹67.13 | -51.7% | EPS: ₹5.00, BVPS: ₹33.10 |
AMANTA Intrinsic Value vs Market Price — All Valuation Models
Amanta Healthcare fair value range ₹38–₹217 vs current market price ₹126.35 across 9 valuation models. Browse Amanta Healthcare financial data for revenue, profit, balance sheet and cash flow data.
AMANTA Intrinsic Value Analysis — Undervalued or Overvalued?
Amanta Healthcare median intrinsic value ₹77.20, current price ₹126.35 — Trading Above Calculated Value by 38.9%, margin of safety -63.7%.
What is the intrinsic value of AMANTA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Amanta Healthcare (AMANTA) is ₹77.20 (median value). With the current market price of ₹126.35, this represents a -38.9% variance from our estimated fair value.
The valuation range spans from ₹37.90 to ₹217.24, indicating ₹37.90 - ₹217.24.
Is AMANTA undervalued or overvalued?
Based on our multi-method analysis, Amanta Healthcare (AMANTA) appears to be trading above calculated value by approximately 38.9%.
AMANTA Financial Health — Key Ratios vs Industry Benchmarks
Amanta Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.81 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 15.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 22.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.75x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
AMANTA Cash Flow Quality — Operating & Free Cash Flow
Amanta Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹47 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹58 Cr | ₹53 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹43 Cr | ₹40 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹62 Cr | ₹59 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹31 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |